Trials / Conditions / Hepatocellular Carcinoma by BCLC Stage
Hepatocellular Carcinoma by BCLC Stage
7 registered clinical trials studyying Hepatocellular Carcinoma by BCLC Stage.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Brazilian Reality of Hepatocellular Carcinoma NCT06230328 | AstraZeneca | — |
| Completed | Testing Immunotherapy for Patients With Liver Cancer and Moderately Altered Liver Functions NCT05622071 | UNICANCER | Phase 2 |
| Unknown | TACE Combined With Bevacizumab in HCC (BCLC-B) Beyond Up-To-Seven Criteria NCT05883176 | Sun Yat-sen University | Phase 2 |
| Unknown | A Trial of Hepatic Arterial Infusion Combined With Bevacizumab and Sintilimab for Unresectable A-staged Hepato NCT05214339 | Sun Yat-sen University | Phase 2 |
| Unknown | Anatomy-based Resection or Margin-based Resection for Hepatocellular Carcinoma NCT03652896 | Huazhong University of Science and Technology | N/A |
| Completed | Volumetric Analysis of Hepatocellular Carcinoma After Transarterial Chemoembolization NCT04780789 | Brno University Hospital | — |
| Completed | Study of Autologous Immune Killer Cells in Patients With Late Stage Hepatocellular Carcinoma or Lung Cancer NCT03515252 | Ivy Life Sciences, Co., Ltd | Phase 1 |